Shen Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Shen Li has a total of 220 co-authors. Here are the top co-authors by number of shared publications:
- Jie Li
Laboratory of Biological Psychiatry, Institute of Mental Health, Tianjin Anding Hospital, Mental Health Center of Tianjin Medical University, Tianjin, China
37 shared publications Yanzhe Li
Laboratory of Biological Psychiatry, Tianjin Anding Hospital, Mental Health Center of Tianjin Medical University, Tianjin 300222, China
29 shared publicationsChenghao Lu
Laboratory of Biological Psychiatry, Tianjin Anding Hospital, Mental Health Center of Tianjin Medical University, Tianjin 300222, China
26 shared publicationsXinxu Wang
Laboratory of Biological Psychiatry, Tianjin Anding Hospital, Mental Health Center of Tianjin Medical University, Tianjin 300222, China
26 shared publicationsNannan Liu
Institute of Mental Health, Tianjin Anding Hospital, Mental Health Center of Tianjin Medical University, Tianjin, China
23 shared publicationsYeqing Dong
Institute of Mental Health, Tianjin Anding Hospital, Mental Health Center of Tianjin Medical University, Tianjin, China
14 shared publications
Latest Publications
- 14 September 2026
- Published by Elsevier in Brain Research
- Vol. 1892, 150549
Integrated proteomics and network pharmacology reveal autophagy-lysosomal regulation underlying sulforaphane-mediated neuroprotection in Alzheimer’s disease
- 14 September 2026
- Published by Elsevier in Brain Research
- Vol. 1892, 150549
Integrated proteomics and network pharmacology reveal autophagy-lysosomal regulation underlying sulforaphane-mediated neuroprotection in Alzheimer’s disease
- 30 August 2026
- Published by Springer Nature in European Archives of Psychiatry and Clinical Neuroscience
- Vol. 276 (7) , 3935-3948
Untargeted plasma metabolomics identifies metabolite signatures associated with suicidality status in chronic schizophrenia
- 30 August 2026
- Published by Springer Nature in European Archives of Psychiatry and Clinical Neuroscience
- Vol. 276 (7) , 3935-3948
Untargeted plasma metabolomics identifies metabolite signatures associated with suicidality status in chronic schizophrenia
- 21 August 2026
- Published by Springer Nature in Molecular Psychiatry
- p. 1-11
HD-tDCS modulation of the DLPFC-HPC-EC pathway to enhance working memory in schizophrenia: a TMS-EEG Study
Schizophrenia (SCZ) is characterized by cognitive impairments, particularly in working memory (WM), which significantly impact patients‘ functional outcomes, yet effective interventions for these cognitive deficits remain limited. This randomized, double-blind, sham-controlled study aimed to investigate whether a single session of high-definition transcranial direct current stimulation (HD-tDCS) targeting the left dorsolateral prefrontal cortex (DLPFC) can improve WM in patients with SCZ and to elucidate the underlying neural mechanisms. A total of 69 patients with SCZ were randomly assigned to active HD-tDCS (n = 34) or sham HD-tDCS (n = 35). WM performance was assessed using a 2-back task, and neural activity was evaluated via TMS-EEG to measure changes in excitability and connectivity across the DLPFC, hippocampus (HPC), and entorhinal cortex (EC). Active HD-tDCS significantly improved WM task accuracy (p < 0.001) and reduced reaction times (p < 0.01) compared to the sham group. TMS-EEG analyses revealed reduced neural excitability in the EC and HPC following active stimulation, with changes in EC activity correlating with improved WM accuracy. Mediation analyses suggested that HD-tDCS modulates WM through a statistically modeled DLPFC-HPC-EC neural pathway, with the HPC acting as a full mediator. These findings provide evidence that a single session of HD-tDCS targeting the DLPFC enhances WM in SCZ patients, potentially by modulating the DLPFC-HPC-EC functional cascade, highlighting its potential as a non-invasive intervention for cognitive impairments in SCZ and offering insights into its underlying mechanisms.
- 21 August 2026
- Published by Springer Nature in Molecular Psychiatry
- p. 1-11
HD-tDCS modulation of the DLPFC-HPC-EC pathway to enhance working memory in schizophrenia: a TMS-EEG Study
Schizophrenia (SCZ) is characterized by cognitive impairments, particularly in working memory (WM), which significantly impact patients‘ functional outcomes, yet effective interventions for these cognitive deficits remain limited. This randomized, double-blind, sham-controlled study aimed to investigate whether a single session of high-definition transcranial direct current stimulation (HD-tDCS) targeting the left dorsolateral prefrontal cortex (DLPFC) can improve WM in patients with SCZ and to elucidate the underlying neural mechanisms. A total of 69 patients with SCZ were randomly assigned to active HD-tDCS (n = 34) or sham HD-tDCS (n = 35). WM performance was assessed using a 2-back task, and neural activity was evaluated via TMS-EEG to measure changes in excitability and connectivity across the DLPFC, hippocampus (HPC), and entorhinal cortex (EC). Active HD-tDCS significantly improved WM task accuracy (p < 0.001) and reduced reaction times (p < 0.01) compared to the sham group. TMS-EEG analyses revealed reduced neural excitability in the EC and HPC following active stimulation, with changes in EC activity correlating with improved WM accuracy. Mediation analyses suggested that HD-tDCS modulates WM through a statistically modeled DLPFC-HPC-EC neural pathway, with the HPC acting as a full mediator. These findings provide evidence that a single session of HD-tDCS targeting the DLPFC enhances WM in SCZ patients, potentially by modulating the DLPFC-HPC-EC functional cascade, highlighting its potential as a non-invasive intervention for cognitive impairments in SCZ and offering insights into its underlying mechanisms.
- 19 August 2026
- Published by Springer Nature in Molecular Psychiatry
- p. 1-10
Metabolic biomarkers of treatment-resistant schizophrenia and cognitive correlates: insights from a machine learning
Early identification of Treatment-resistant schizophrenia (TRS) remains a challenge. Metabolomics offers a promising strategy for identifying biomarkers and uncovering the metabolic alterations underlying TRS. Machine learning (ML), increasingly applied in omics research, enables the development of predictive models from complex datasets. This study aimed to develop a metabolomics-based ML model for TRS identification and to examine its association with cognitive impairments. 112 TRS patients, 232 non-TRS patients, and 145 sex- and age-matched healthy controls were recruited in this study. Psychiatric symptoms were assessed using the Positive and Negative Syndrome Scale (PANSS), and cognitive function was evaluated with the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) and the Toronto Alexithymia Scale (TAS-26). Fasting blood samples were collected from all participants and analyzed by UHPLC-HRMS, enabling the quantification and profiling of 699 metabolites. The resulting data were then subjected to orthogonal partial least squares discriminant analysis (OPLS-DA), and a predictive model was constructed using a random forest algorithm, which was validated through 5 × 5 nested cross-validation with inner-loop LASSO feature selection. From 699 metabolites, 58 metabolites exhibited significant changes (VIP > 1.5, FDR p < 0.05). 5 × 5 nested cross-validation combining an inner-loop LASSO feature selection model yielded a pooled out-of-fold AUC of 0.958 (95% CI (DeLong): 0.940–0.977) for TRS classification. Further correlation analyses revealed distinct associations between the top five predictive metabolites and cognitive domains in TRS versus non-TRS patients. Gamma-glutamylthreonine (gamma-Glu-Thr) showed a significant negative correlation with visuospatial cognition in TRS patients (r = −0.25, p = 0.009). In contrast, it showed a positive correlation in the non-TRS group (r = 0.16, p = 0.015). However, these associations did not remain significant after FDR correction. This study established an RF-metabolomic model for identifying TRS and provided specific metabolic signatures associated with cognitive dysfunction.
- 19 August 2026
- Published by Springer Nature in Molecular Psychiatry
- p. 1-10
Metabolic biomarkers of treatment-resistant schizophrenia and cognitive correlates: insights from a machine learning
Early identification of Treatment-resistant schizophrenia (TRS) remains a challenge. Metabolomics offers a promising strategy for identifying biomarkers and uncovering the metabolic alterations underlying TRS. Machine learning (ML), increasingly applied in omics research, enables the development of predictive models from complex datasets. This study aimed to develop a metabolomics-based ML model for TRS identification and to examine its association with cognitive impairments. 112 TRS patients, 232 non-TRS patients, and 145 sex- and age-matched healthy controls were recruited in this study. Psychiatric symptoms were assessed using the Positive and Negative Syndrome Scale (PANSS), and cognitive function was evaluated with the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) and the Toronto Alexithymia Scale (TAS-26). Fasting blood samples were collected from all participants and analyzed by UHPLC-HRMS, enabling the quantification and profiling of 699 metabolites. The resulting data were then subjected to orthogonal partial least squares discriminant analysis (OPLS-DA), and a predictive model was constructed using a random forest algorithm, which was validated through 5 × 5 nested cross-validation with inner-loop LASSO feature selection. From 699 metabolites, 58 metabolites exhibited significant changes (VIP > 1.5, FDR p < 0.05). 5 × 5 nested cross-validation combining an inner-loop LASSO feature selection model yielded a pooled out-of-fold AUC of 0.958 (95% CI (DeLong): 0.940–0.977) for TRS classification. Further correlation analyses revealed distinct associations between the top five predictive metabolites and cognitive domains in TRS versus non-TRS patients. Gamma-glutamylthreonine (gamma-Glu-Thr) showed a significant negative correlation with visuospatial cognition in TRS patients (r = −0.25, p = 0.009). In contrast, it showed a positive correlation in the non-TRS group (r = 0.16, p = 0.015). However, these associations did not remain significant after FDR correction. This study established an RF-metabolomic model for identifying TRS and provided specific metabolic signatures associated with cognitive dysfunction.
- 14 August 2026
- Published by Elsevier in Asian Journal of Psychiatry
- Vol. 124, 105124
Individualized temporal interference stimulation targeting the right nucleus accumbens in schizophrenia: An open-label pilot study
- 14 August 2026
- Published by Elsevier in Asian Journal of Psychiatry
- Vol. 124, 105124
Individualized temporal interference stimulation targeting the right nucleus accumbens in schizophrenia: An open-label pilot study
- 23 July 2026
- Published by Elsevier in Schizophrenia Research
- Vol. 296, 218-226
Metabolomics analysis reveals BMI-related metabolic characteristics in schizophrenia patients
- 23 July 2026
- Published by Elsevier in Schizophrenia Research
- Vol. 296, 218-226
Metabolomics analysis reveals BMI-related metabolic characteristics in schizophrenia patients
- Open Access
- 23 July 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 8960
Dyscoordination of thalamic reticular spindles is associated with social memory deficits in mice and humans with autism spectrum disorder
Social memory, the ability to recognize and remember conspecifics, is frequently impaired in psychiatric disorders such as autism, yet the underlying mechanisms remain unclear. We examined the role of sleep spindles across non-rapid eye movement sleep in social memory consolidation, focusing on the sensory thalamic reticular nucleus (sTRN). Here we show that impaired spindles were associated with defective social memory. Through pharmacological/optogenetic manipulations and optical Ca2+ recordings, we demonstrated that parvalbumin-positive neurons in the sTRN (sTRNPvalb) are essential for sleep spindle generation, mediated by the sTRNPvalb–ventroposteromedial (VPM) thalamic nucleus circuit. Increasing the activity of the sTRNPvalb–VPM pathway could rescue impaired spindles and social memory deficits in Neuroligin 2 mutant mice. Moreover, we developed machine learning-based models to predict autism in children based on spindle eigenvalues. These findings underscore the critical role of spindles in social memory, suggesting spindles may serve as candidate diagnostic markers.
- 23 July 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 8960
Open AccessDyscoordination of thalamic reticular spindles is associated with social memory deficits in mice and humans with autism spectrum disorder
Social memory, the ability to recognize and remember conspecifics, is frequently impaired in psychiatric disorders such as autism, yet the underlying mechanisms remain unclear. We examined the role of sleep spindles across non-rapid eye movement sleep in social memory consolidation, focusing on the sensory thalamic reticular nucleus (sTRN). Here we show that impaired spindles were associated with defective social memory. Through pharmacological/optogenetic manipulations and optical Ca2+ recordings, we demonstrated that parvalbumin-positive neurons in the sTRN (sTRNPvalb) are essential for sleep spindle generation, mediated by the sTRNPvalb–ventroposteromedial (VPM) thalamic nucleus circuit. Increasing the activity of the sTRNPvalb–VPM pathway could rescue impaired spindles and social memory deficits in Neuroligin 2 mutant mice. Moreover, we developed machine learning-based models to predict autism in children based on spindle eigenvalues. These findings underscore the critical role of spindles in social memory, suggesting spindles may serve as candidate diagnostic markers.